Cargando…
Pancreatic β cell regeneration induced by clinical and preclinical agents
Diabetes, one of the most common chronic diseases in the modern world, has pancreatic β cell deficiency as a major part of its pathophysiological mechanism. Pancreatic regeneration is a potential therapeutic strategy for the recovery of β cell loss. However, endocrine islets have limited regenerativ...
Autores principales: | Wang, Kang-Li, Tao, Ming, Wei, Tian-Jiao, Wei, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859987/ https://www.ncbi.nlm.nih.gov/pubmed/33584980 http://dx.doi.org/10.4252/wjsc.v13.i1.64 |
Ejemplares similares
-
Antler stem cells and their potential in wound healing and bone regeneration
por: Zhang, Wei, et al.
Publicado: (2021) -
Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola
por: Yan, Victoria C., et al.
Publicado: (2021) -
Vascular disrupting agents in clinical development
por: Hinnen, P, et al.
Publicado: (2007) -
Mesenchymal stem cells for cartilage regeneration in osteoarthritis
por: Kristjánsson, Baldur, et al.
Publicado: (2017) -
Hepatic encephalopathy: Lessons from preclinical studies
por: Lima, Luiza Cioglia Dias, et al.
Publicado: (2019)